4.4 Article

Progressive lentivirus infection induces natural killer cell receptor-expressing B cells in the gastrointestinal tract

Journal

AIDS
Volume 32, Issue 12, Pages 1571-1578

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/QAD.0000000000001855

Keywords

B cell; innate immunity; macaques; natural killer cell; simian immunodeficiency virus

Funding

  1. National Institutes of Health [P01 AI120756, R01 DE026014, R01 DE026327, R01 AI20828]
  2. Harvard Center for AIDS Research [P30 AI060354]

Ask authors/readers for more resources

Objective: Recently, a seemingly novel innate immune cell subset bearing features of natural killer and B cells was identified in mice. So-called NKB cells appear as first responders to infections, but whether this cell population is truly novel or is in fact a subpopulation of B cells and exists in higher primates remains unclear. The objective of this study was to identifyNKB cells in primates and study the impact of HIV/SIV-infections. Design and Methods: NKB cells were quantified in both naive and lentivirus infected rhesus macaques and humans by excluding lineage markers (CD3, CD127) and positive Boolean gating for CD20, NKG2A/C and/or NKp46. Additional phenotypic measures were conducted by RNA-probe and traditional flow cytometry. Results: Circulating cytotoxic NKB cells were found at similar frequencies in humans and rhesus macaques (range, 0.01-0.2% of total lymphocytes). NKB cells were notably enriched in spleen (median, 0.4% of lymphocytes), but were otherwise systemically distributed in tonsil, lymph nodes, colon, and jejunum. Expression of immunoglobulin was highly variable, but heavily favoured IgM and IgA rather than IgG. Interestingly, NKB cell frequencies expanded in PBMC and colon during SIV infection, as did IgG expression, but were generally unaltered in HIV-infected humans. Conclusion: These results suggest a cell type expressing both natural killer and B-cell features exists in rhesus macaques and humans and are perturbed by HIV/SIV infection. The full functional niche remains unknown, but the unique phenotype and systemic distribution could make NKB cells unique targets for immunotherapeutics or vaccine strategies. Copyright (C) 2018 Wolters Kluwer Health, Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available